Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment
| dc.contributor.author | Sousa, Angela | |
| dc.contributor.author | Soares, Christiane Pienna [UNESP] | |
| dc.contributor.author | Dos Santos, Jean Leandro [UNESP] | |
| dc.contributor.institution | Univ Beira Interior | |
| dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
| dc.date.accessioned | 2021-06-25T15:02:38Z | |
| dc.date.available | 2021-06-25T15:02:38Z | |
| dc.date.issued | 2021-04-06 | |
| dc.description.affiliation | Univ Beira Interior, CICS UBI Hlth Sci Res Ctr, Covilha, Portugal | |
| dc.description.affiliation | Sao Paulo State Univ, Sch Pharmaceut Sci, Clin Anal Dept, Araraquara, SP, Brazil | |
| dc.description.affiliation | Sao Paulo State Univ, Sch Pharmaceut Sci, Drugs & Med Dept, Araraquara, SP, Brazil | |
| dc.description.affiliationUnesp | Sao Paulo State Univ, Sch Pharmaceut Sci, Clin Anal Dept, Araraquara, SP, Brazil | |
| dc.description.affiliationUnesp | Sao Paulo State Univ, Sch Pharmaceut Sci, Drugs & Med Dept, Araraquara, SP, Brazil | |
| dc.description.sponsorship | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | |
| dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
| dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
| dc.description.sponsorship | FEDER funds through the POCI-COMPETE 2020-Operational Programme Competitiveness and Internationalization in Axis I-Strengthening research, technological development and innovation | |
| dc.description.sponsorship | FCT-Foundation for Science and Technology | |
| dc.description.sponsorshipId | CAPES: 001 | |
| dc.description.sponsorshipId | FAPESP: 2018/11079-0 | |
| dc.description.sponsorshipId | CNPq: 304731/2017-0 | |
| dc.description.sponsorshipId | FEDER funds through the POCI-COMPETE 2020-Operational Programme Competitiveness and Internationalization in Axis I-Strengthening research, technological development and innovation: POCI-01-0145-FEDER-007491 | |
| dc.description.sponsorshipId | FCT-Foundation for Science and Technology: UID/Multi/00709/2019 | |
| dc.format.extent | 2 | |
| dc.identifier | http://dx.doi.org/10.3389/fcell.2021.662761 | |
| dc.identifier.citation | Frontiers In Cell And Developmental Biology. Lausanne: Frontiers Media Sa, v. 9, 2 p., 2021. | |
| dc.identifier.doi | 10.3389/fcell.2021.662761 | |
| dc.identifier.issn | 2296-634X | |
| dc.identifier.lattes | 1768025290373669 | |
| dc.identifier.orcid | 0000-0003-1740-7360 | |
| dc.identifier.uri | http://hdl.handle.net/11449/210247 | |
| dc.identifier.wos | WOS:000641259200001 | |
| dc.language.iso | eng | |
| dc.publisher | Frontiers Media Sa | |
| dc.relation.ispartof | Frontiers In Cell And Developmental Biology | |
| dc.source | Web of Science | |
| dc.subject | cancer treatment | |
| dc.subject | cellular mechanisms | |
| dc.subject | drugs | |
| dc.subject | epigenetics | |
| dc.subject | histone deacetylase inhibitors | |
| dc.subject | molecular biology | |
| dc.title | Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment | en |
| dc.type | Editorial | pt |
| dcterms.rightsHolder | Frontiers Media Sa | |
| dspace.entity.type | Publication | |
| relation.isDepartmentOfPublication | a83d26d6-5383-42e4-bb3c-2678a6ddc144 | |
| relation.isDepartmentOfPublication | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
| relation.isDepartmentOfPublication.latestForDiscovery | a83d26d6-5383-42e4-bb3c-2678a6ddc144 | |
| unesp.author.lattes | 1768025290373669[2] | |
| unesp.author.orcid | 0000-0001-9155-7581[1] | |
| unesp.author.orcid | 0000-0003-1740-7360[2] | |
| unesp.department | Análises Clínicas - FCF | pt |
| unesp.department | Fármacos e Medicamentos - FCF | pt |

